Allergan
Case Analysis
Allemande Left, then Do-Si-Do,
Find a Partner
(2004)
Team 2
THE CURRENT SITUATION
A. Current Performance
Allergan is one of the smaller pharmaceutical companies in the industry, it's product lines include ophthalmology, neuromodulator, and dermatology. Allergan has experienced recorded sales growth; 16% over the previous year. As Allergan entered 2004, it has a strong pipeline of projects, with most of its resources focusing on ophthalmology and neuromodulator businesses. The company has indicated a desire to expand its smallest platform (i.e., dermatology) via external resources.
B. Strategic Posture
1. Mission:
Improving Lives: For more than half a century, Allergan's mission has remained constant: to deliver high quality products to our customers, and satisfy unmet medical needs, and improve patients' lives.
To develop a unique level of understanding of our customers in order to implement operational strategies that......
Join Now or Login to view the rest of this paper.
Approximate Word Count: 11373
Approximate Pages: 44 (260 words per double-spaced page) |